Evidence map›Paper›PMID 37155029›Full record

ArticleBiomolecular NMR assignments2023

Solution NMR backbone assignment of the SASH1 SLy proteins associated disordered region (SPIDER).

Christopher M Clements, Beat Vögeli, Yiqun G Shellman, Morkos A Henen

Open access · greenAbstract read
In one paragraph

Article in Biomolecular NMR assignments, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.8field-weighted citation impact, top 28% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 5 citations in OpenAlex.

  1. Review
  2. Article
  3. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Christopher M ClementsDepartment of Dermatology, School of Medicine, University of Colorado Anschutz Medical Campus, Aurora, CO, 80045, USA.
Beat VögeliDepartment of Biochemistry and Molecular Genetics, School of Medicine, University of Colorado Anschutz Medical Campus, Aurora, CO, 80045, USA. beat.vogeli@cuanschutz.edu.
Yiqun G Shellman *Department of Dermatology, School of Medicine, University of Colorado Anschutz Medical Campus, Aurora, CO, 80045, USA. yiqun.shellman@cuanschutz.edu.
Morkos A Henen *Department of Biochemistry and Molecular Genetics, School of Medicine, University of Colorado Anschutz Medical Campus, Aurora, CO, 80045, USA. morkos.henen@cuanschutz.edu.
University of Colorado Anschutz Medical Campus · US

Funding

University of Colorado Cancer Center Support Grant - Lung Cancer Patient-Derived Xenografts with Autologous Human Immune SystemsP30CA046934 · NCI · UNIVERSITY OF COLORADO DENVER · PI James V Degregori · 1988 to 2026
$117.0M
Study of melanocyte lineage through SASH1 and associated proteinsR01AR074420 · NIAMS · UNIVERSITY OF COLORADO DENVER · PI SHELLMAN, YIQUN G · 2020 to 2024
$2.2M
Dynein-adaptor interaction mechanisms and malfunction at atomic resolutionR01GM130694 · NIGMS · UNIVERSITY OF COLORADO DENVER · PI VOGELI, BEAT ROLF · 2019 to 2022
$1.3M
600 MHz NMR console and cold probeS10OD025020 · OD · UNIVERSITY OF COLORADO DENVER · PI JONES, DAVID NIGEL · 2018 to 2018
$501k
Small molecule inhibitors targeting the SARS-CoV-2 pathogenicity factor Nsp1R21AI171827 · NIAID · COLUMBIA UNIVERSITY HEALTH SCIENCES · PI HENEN, MORKOS, STECKELBERG, ANNA-LENA · 2022 to 2023
$458k
NCI NIH HHS P30 CA046934NIAID NIH HHS R21 AI171827NIAMS NIH HHS R01 AR074420NIGMS NIH HHS R01 GM130694NIH HHS S10 OD025020
6 · The paper itself

Abstract

SASH1 is a scaffold protein with context-dependent biological functions in cell adhesion, tumor metastasis, lung development, and pigmentation. As a member of the SLy protein family, it contains the conserved SLY, SH3, and SAM domains. The 19 kDa SLY domain harbors over 70% of the SASH1 variants associated with pigmentation disorders. However, its solution structure or dynamics have not been investigated yet, and its exact position in the sequence is not clearly defined. Based on the bioinformatic and experimental evidence, we propose renaming this region to the SLy Proteins Associated Disordered Region (SPIDER) and defining the exact position to be amino acids 400-554 of SASH1. We have previously identified a variant in this region linked to a pigmentation disorder, S519N. Here, we used a novel deuteration technique, a suite of TROSY-based 3D NMR experiments, and a high-quality HNN to obtain near complete solution backbone assignment of SASH1's SPIDER. A comparison with the chemical shifts of non-variant (S519) SPIDER shows that the S519N substitution does not alter the free form solution structural propensities of SPIDER. This assignment is the first step to characterize the role of SPIDER in SASH1-mediated cellular functions and provides a model for the future study of sister SPIDER domains in the SLy protein family.

Indexed as

Tumor Suppressor ProteinsCell Line, TumorCell MovementMagnetic Resonance SpectroscopyNuclear Magnetic Resonance, BiomolecularSASH1 protein, humanTumor Suppressor ProteinsPigmentationProtein domainsSLy3SLy-familySSP

Identifiers

PMID37155029
PMCPMC10291481
OpenAlexW4375867325

What Socratic holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.